Interestingly, while anti-PD-1 consistently exhibited efficacy, the synergistic effect of the combination therapy was abolished in Trp53-knockout mice bearing Trp53mut MC38 tumor (Fig. 5). Here, PDCD1 is linked to neoplasm.